Release Date: 31/01/20 12:24 Summary: Appendix 4C - Cashflow Report - Quarter ended 31 Dec 2019 Price Sensitive: Yes Download Document 216.75KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status